The Association of the British Pharmaceutical Industry (ABPI)  Code of Practice is to be revised following the publication of a European-wide code on relationships between the pharmaceutical industry and patient organisations, announced the Association of the British Pharmaceutical Industry (ABPI)

The ABPI code, which sets out rules to govern the behaviour of UK-based pharmaceutical companies and their employees, is required to include all the provisions of the code administered by the European Federation of Pharmaceutical Industries and Associations (EFPIA). The ABPI and other national trade associations in Europe worked with EFPIA to develop and draft this new code.

Most of the provisions of the new EFPMA code are already requirements under the ABPI code but some, covering aspects of pharmaceutical companies' relationships with patient organisations, will need to be incorporated.  Changes in relation to the EFPIA code must be implemented into the ABPI code by July 1, 2008. Examples include a new requirement on companies to include a short description of the nature of the support provided to patient organisations. As well as financial backing, indirect, non-financial support will also need to be declared.